Imunon, Inc. Other Non-Current Assets
Imunon, Inc. (IMNN) had Other Non-Current Assets of $5.84 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $5.84M.
- 2026-03-31: Other Assets, Noncurrent $937.89K.
- 2025-12-31: Other Assets, Noncurrent $1.03M.
- 2025-09-30: Other Assets, Noncurrent $1.13M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $5.84M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $937.89K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.03M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.22M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.04M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.17M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.30M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.42M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.54M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $2.93M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $2.11M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.34M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $5.22M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.65M 10-K · filed 2024-03-28 | $6.27M 10-K · filed 2023-03-30 |
| 2022-09-30 | $19.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.86M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $19.99M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $21.62M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $22.22M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $22.24M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $16.40M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $18.41M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $21.64M 10-K · filed 2021-03-19 | |
| 2017-12-31 | $8.76K 10-K · filed 2018-03-27 | |
| 2016-12-31 | $8.76K 10-K · filed 2018-03-27 | |
| 2012-12-31 | $595.31K 10-K · filed 2013-03-18 | |
| 2011-12-31 | $358.25K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |